As of the latest Form 4 filed Jun 26, 2026.
What Arvinas Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 29 most recent filings for ARVN.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-26 | 2026-06-24 | Smaldone Alsup Laurie Director | AAward | +15.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Norwalk Leslie V Director | AAward | +15.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Morrison Briggs Director | AAward | +15.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Kennedy Edward Moore Jr. Director | AAward | +15.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Cunningham Everett Director | AAward | +15.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Bain Linda Director | AAward | +15.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-24 | Saik Andrew Chief Financial Officer | SSale | −5.70K | $8.16 | $46.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-18 | 2026-06-17 | Cacace Angela M Chief Scientific Officer | SSale | −2.58K | $7.60 | $19.6K | Yes (planned) | Form 4 ↗ |
| 2026-05-22 | 2026-05-21 | Teel Randy President and CEO | SSale | −2.21K | $9.04 | $20.0K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Saik Andrew Chief Financial Officer | SSale | −11.1K | $9.94 | $111K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Loomis David K VP, Chief Accounting Officer | SSale | −1.92K | $9.94 | $19.1K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Cacace Angela M Chief Scientific Officer | SSale | −9.66K | $9.94 | $96.0K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Berkowitz Noah Chief Medical Officer | SSale | −11.1K | $9.94 | $110K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Teel Randy President and CEO | SSale | −9.66K | $9.94 | $96.0K | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-18 | Berkowitz Noah Chief Medical Officer | SSale | −6.43K | $11.10 | $71.4K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-06 | Morrison Briggs Director | PPurchase | +20.0K | $13.40 | $268K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Houston John G Director | SSale | −11.8K | $13.14 | $155K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Houston John G, Director | SSale | −18.8K | $13.24 | $249K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Houston John G, Director | SSale | −4.69K | $13.24 | $62.1K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Loomis David K VP, Chief Accounting Officer | AAward | +12.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Cacace Angela M Chief Scientific Officer | AAward | +45.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Berkowitz Noah Chief Medical Officer | AAward | +45.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Saik Andrew Chief Financial Officer | AAward | +45.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Teel Randy President and CEO | AAward | +148K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Loomis David K Chief Accounting Officer | SSale | −1.11K | $12.16 | $13.5K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Cacace Angela M Chief Scientific Officer | SSale | −2.57K | $12.16 | $31.3K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Cacace Angela M, Chief Scientific Officer | SSale | −1.04K | $12.16 | $12.6K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Teel Randy President and CEO | SSale | −3.75K | $12.16 | $45.6K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Teel Randy, President and CEO | SSale | −1.04K | $12.16 | $12.6K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ARVN’s full analysis or the market-wide insider trading feed. The tabs above jump to ARVN’s other SEC data.
Source: SEC Form 4 filings for ARVN, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.